Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

A. Moran, B. Bundy, D. J. Becker, L. A. DiMeglio, S. E. Gitelman, R. Goland, C. J. Greenbaum, K. C. Herold, J. B. Marks, Philip Raskin, S. Sanda, D. Schatz, D. Wherrett, D. M. Wilson, J. P. Krischer, J. S. Skyler, L. Pickersgill, E. De Koning, A. G. Ziegler, B. BöehmK. Badenhoop, N. Schloot, J. F. Bak, P. Pozzilli, D. Mauricio, M. Y. Donath, L. Castaño, A. Wägner, H. H. Lervang, H. Perrild, T. Mandrup-Poulsen

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S87
JournalDiabetes Technology and Therapeutics
Volume16
Issue numberSUPPL. 1
DOIs
StatePublished - 2014

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this